Stay updated on Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed trial information regarding Mylan's insulin glargine and its comparison to Lantus®, while adding a new revision number and collaborators.SummaryDifference18%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check71 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Insulin Glargine in Type 2 Diabetes Clinical Trial page.